Cubist Systematic Strategies’s Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share NGC.WS Stock Holding History
Bought
Maintained
Sold
Cubist Systematic Strategies's NGC.WS Position: Q1 2023 in Review
Cubist Systematic Strategies sold out of Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share (NGC.WS) in Q1 2023, closing a stake of 20,489 shares — an estimated $1.72K sold.
Cubist Systematic Strategies first reported a position in NGC.WS in Q3 2022 and held it in 2 quarters. The position peaked at $1.72K in Q4 2022. 0 funds tracked by Wall St. Rank hold NGC.WS as of Q1 2023.
- Cubist Systematic Strategies reported no remaining Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
- Cubist Systematic Strategies sold 20,489 Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share shares in Q1 2023, an estimated $1.72K.
- Cubist Systematic Strategies first reported a position in Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share in Q3 2022 and held it in 2 quarters.
- Cubist Systematic Strategies's Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share position peaked at $1.72K in Q4 2022.
- 0 funds tracked by Wall St. Rank held Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share as of Q1 2023.
Based on Cubist Systematic Strategies's 13F filing for Q1 2023, filed 15 May 2023.